Blog - Archive for Health Care Law News

Federal Trade Commission Proposes Complete Ban on Non-Compete Provisions

Posted on Employment Law News, Health Care Law News February 1, 2023 by Rachel Broughton

On January 5, 2023, the Federal Trade Commission (“FTC”) issued a proposed rule that would apply retroactively and prohibit employers from utilizing non-compete clauses with employees. If this proposed rule were to pass, it would require that all employers rescind all existing non-competes and provide notice to all of its current and former employees that Read more →

Tags :

The Importance of Examining Fair Market Value in the Healthcare Industry

Posted on Health Care Law News November 11, 2022 by Rachel Broughton

 Health care is one of the most highly regulated industries in the United States. Whenever anything of value is exchanged among health care providers or between health care providers and third parties, the value of the exchange may need to be at fair market value (“FMV”), or the parties may open their practice (and potentially Read more →

Tags :

Deputy Attorney General Announces Significant Changes to DOJ Policies Regarding Corporate Investigations and Voluntary Self-Disclosure Incentives

Posted on Fraud Investigation, Health Care Law News October 7, 2022 by Rachel Broughton

On September 15, 2022, Deputy Attorney General Lisa Monaco published a memorandum which laid out the Department of Justice’s (DOJ) new guidelines for policies regarding corporate investigations and voluntary self-disclosures. The DOJ announced it would expand and/or clarify its policies on voluntary self-disclosure, making it its goal to reward companies that have invested in compliance Read more →

Tags :

Understanding Insurance Audits in the Health Care Industry

Posted on Health Care Law News August 5, 2022 by Rachel Broughton

Aggressive insurance audits have become increasingly common within the health care industry, and all health care providers who bill insurers are susceptible to audits from those payers, whether it be the government (such as Medicaid or Medicare) or private insurance companies. While private insurance companies each have their own policies and procedures with respect to Read more →

Tags :

US DOJ Announces Criminal Charges for $1.2 Billion in Telemedicine, Cardiovascular and Cancer Genetic Testing and DME Fraud

Posted on Fraud Investigation, Health Care Law News July 21, 2022 by Rachel Broughton

On Wednesday, July 20, 2022, the United States Department of Justice (DOJ) announced criminal charges against 36 defendants in 13 federal districts across the United States for more than $1.2 billion in alleged fraudulent telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment (DME) schemes. In connection with the enforcement action, the department seized Read more →

Tags :